Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | DJI136 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on DJI136, a putative chimeric antigen receptor (CAR) T-cell therapy targeting DLL3 (Jun 2026). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| DJI136 | DJI-136|DJI 136 | Limited information is currently available on DJI136, a putative chimeric antigen receptor (CAR) T-cell therapy targeting DLL3 (Jun 2026). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07564401 | Phase Ib/II | DJI136 | A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy | Recruiting | USA | 1 |